From the Journals
Conference News
Dalbavancin Exposure Linked to Higher Success in Bacteremia
Higher day 22 concentrations were associated with improved outcomes, though findings remain exploratory
-
By
-
Kathryn Wighton
-
May 6, 2026
-
-
1
Higher dalbavancin exposure correlates with improved clinical success.
-
2
77% of patients achieved success by day
-
3
Key pharmacokinetic factors: creatinine clearance, body weight.
-
4
Higher concentrations associated with more adverse events.
-
5
Study highlights need for personalized dosing strategies.
-
6
Findings are hypothesis-generating for future research.
-
7
Funded by the National Institute of Allergy and Infectious Diseases.
